Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 13 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Avoiding conflict in update in distributed environment employing multiple clients
SRB enhancement on HS-DSCH during cell change
Systems and methods for cryopreservation of cells
Battery comprising circuitry for charge and discharge control, and method of operating a battery
Scalable architecture for rank order filtering
Methods of implanting dopant ions
Predicting performance of an integrated circuit
  Randomly Featured Patents
Memory write error correction circuit
Bullet trap for a shooting stand
Pet litter scoop
Electric steam iron with improved water tank and skirt assembly
Adjustable-length spine-immobilizing backboard
Fishing reel
Apparatus and method for transmitting reverse packet data in mobile communication system
Servo control system
Node predisposition circuit
Radio communication system and destination portable terminal time identification method